drugset / Trial / NCT01515371
Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to identify out of up to three doses a safe and effective dose of Botulinum toxin type A for an injection into one side of the soft palate to treat snoring.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-09
- Completion
- 2012-11
Outcome
Outcome not reported
Stopped: “Due to lack of sufficient eligible subjects, no safety concerns”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 2.5 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 5 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 7.4 iu | Other |